These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 9186852

  • 1. HCV and hypogammaglobulinemia.
    Sierra FJ, Gil-Aguado A, Echevarria JM, León P, Martin JC, Lavilla P, Garcia Rodriguez MC, Fontan G.
    J Hepatol; 1997 May; 26(5):1158-9. PubMed ID: 9186852
    [No Abstract] [Full Text] [Related]

  • 2. Hepatitis C virus infection in Italian patients with hypogammaglobulinemia.
    Quinti I, Pandolfi F, Paganelli R, Giovannetti A, Sacco G, Oliva A, Aiuti F.
    Clin Ther; 1996 May; 18 Suppl B():96-107. PubMed ID: 8930447
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin.
    Bjøro K, Frøland SS, Yun Z, Samdal HH, Haaland T.
    N Engl J Med; 1994 Dec 15; 331(24):1607-11. PubMed ID: 7526215
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis C virus infection in hypogammaglobulinemic patients receiving long-term replacement therapy with intravenous immunoglobulin.
    Taliani G, Guerra E, Rosso R, Badolato MC, Luzi G, Sacco G, Lecce R, De Bac C, Aiuti F.
    Transfusion; 1995 Feb 15; 35(2):103-7. PubMed ID: 7825204
    [Abstract] [Full Text] [Related]

  • 5. Intravenous immunoglobulin and hepatitis C virus: the Boston episode.
    Schneider LC, Jonas MM, Baron MJ, Mast EF, Alter MJ, Schonberger LB, Lambert S, Coleman P, Bresee JS.
    Clin Ther; 1996 Feb 15; 18 Suppl B():108-9. PubMed ID: 8930448
    [No Abstract] [Full Text] [Related]

  • 6. Hepatitis C transmission associated with intravenous immunoglobulins.
    Yu MW, Mason BL, Guo ZP, Tankersley DL, Nedjar S, Mitchell FD, Biswas RM.
    Lancet; 1995 May 06; 345(8958):1173-4. PubMed ID: 7536874
    [No Abstract] [Full Text] [Related]

  • 7. Hepatitis C transmission associated with intravenous immunoglobulins.
    Nübling CM, Willkommen H, Löwer J.
    Lancet; 1995 May 06; 345(8958):1174. PubMed ID: 7536875
    [No Abstract] [Full Text] [Related]

  • 8. Quantitative HCV RNA and effect of interferon therapy in chronic hepatitis C.
    Yamada G, Takahashi M, Tsuji T, Yoshizawa H, Okamoto H.
    Dig Dis Sci; 1992 Dec 06; 37(12):1926-7. PubMed ID: 1282100
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical and virological aspects of hepatitis C virus infection in liver transplantation].
    Féray C, Samuel D, Reynès M, Bismuth H.
    Gastroenterol Clin Biol; 1995 Mar 06; 19(3):297-301. PubMed ID: 7540159
    [No Abstract] [Full Text] [Related]

  • 10. Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study.
    Bresee JS, Mast EE, Coleman PJ, Baron MJ, Schonberger LB, Alter MJ, Jonas MM, Yu MY, Renzi PM, Schneider LC.
    JAMA; 1996 Nov 20; 276(19):1563-7. PubMed ID: 8918853
    [Abstract] [Full Text] [Related]

  • 11. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.
    Healey CJ, Sabharwal NK, Daub J, Davidson F, Yap PL, Fleming KA, Chapman RW, Simmonds P, Chapel H.
    Gastroenterology; 1996 Apr 20; 110(4):1120-6. PubMed ID: 8613001
    [Abstract] [Full Text] [Related]

  • 12. Intravenous immunoglobulin and hepatitis C virus: the British episode.
    Healey C, Chapel H.
    Clin Ther; 1996 Apr 20; 18 Suppl B():93-5. PubMed ID: 8930446
    [No Abstract] [Full Text] [Related]

  • 13. [Change of HCV-RNA levels in liver tissue and interferon responsiveness in patients with chronic hepatitis C].
    Takeuchi M, Kaneko S, Unoura M, Kobayashi K.
    Nihon Rinsho; 1995 Sep 20; 53 Suppl(Pt 1):969-74. PubMed ID: 7563912
    [No Abstract] [Full Text] [Related]

  • 14. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin.
    Jonas MM, Baron MJ, Bresee JS, Schneider LC.
    Pediatrics; 1996 Aug 20; 98(2 Pt 1):211-5. PubMed ID: 8692620
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis C virus transmission by intravenous immunoglobulin.
    Farrugia A, Walker E.
    Lancet; 1995 Aug 05; 346(8971):373; author reply 374-5. PubMed ID: 7542718
    [No Abstract] [Full Text] [Related]

  • 16. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission.
    Berger A, Doerr HW, Scharrer I, Weber B.
    J Med Virol; 1997 Sep 05; 53(1):25-30. PubMed ID: 9298728
    [Abstract] [Full Text] [Related]

  • 17. [HCV-RNA quantity of the serum].
    Sasaki Y, Hige S, Nagasaka A, Matsushima T.
    Nihon Rinsho; 1995 Sep 05; 53 Suppl(Pt 1):965-8. PubMed ID: 7563911
    [No Abstract] [Full Text] [Related]

  • 18. [HCV-RNA of the hepatocytes of the complete responders with disappearance serum HCV-RNA after IFN treatment--using in situ hybridization].
    Terada M.
    Nihon Rinsho; 1995 Sep 05; 53 Suppl(Pt 1):944-8. PubMed ID: 7563906
    [No Abstract] [Full Text] [Related]

  • 19. Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up.
    Christie JM, Healey CJ, Watson J, Wong VS, Duddridge M, Snowden N, Rosenberg WM, Fleming KA, Chapel H, Chapman RW.
    Clin Exp Immunol; 1997 Oct 05; 110(1):4-8. PubMed ID: 9353141
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis C virus transmission by intravenous immunoglobulin.
    James RC, Mosley JW.
    Lancet; 1995 Aug 05; 346(8971):374; author reply 374-5. PubMed ID: 7542719
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.